Anusol

Anusol is a brand of medicines intended to relieve symptoms associated with hemorrhoids and related anorectal irritation. Its range has included topical creams, ointments, and suppositories, giving consumers different dosage forms for external or internal symptom management. In Canada, the brand is positioned within the non-prescription, self-care segment, although the legal classification of particular products can vary by jurisdiction and formulation. The brand is associated with products that aim to ease discomfort such as irritation, itching, soreness, and inflammation-related symptoms rather than treat the underlying causes of hemorrhoidal disease. Product formulations have used astringent and soothing active ingredients. Historical descriptions of Anusol ointment and suppositories identify zinc sulfate monohydrate as an active ingredient, while Anusol Plus has been associated with zinc sulfate monohydrate combined with pramoxine hydrochloride, a local antipruritic intended to reduce itching. Reference material also notes that some current formulations use zinc oxide in place of zinc sulfate monohydrate. Because formulations and regulatory registrations can change, the active ingredients and permitted indications should be confirmed from current Canadian packaging and official medicine information. Anusol has not used the same name in every market. In the United States and some other areas, products with the same or substantially comparable brand heritage have been marketed under the Tucks name, while Anusol remains the name used in Canada, the United Kingdom, and other markets. The relationship between names is principally relevant to brand architecture and market presentation; consumers should still rely on the local product label because formulation, dosage form, directions, and regulatory status may differ. The available reference material does not establish a reliable founding year, original founder, corporate headquarters, current owner, manufacturer, or documented sequence of ownership changes. It also does not provide a dated account of major advertising campaigns, acquisitions, leadership appointments, recalls, lawsuits, or other corporate events. Accordingly, this entry treats Anusol primarily as a continuing medicine brand whose publicly documented identity is defined by its hemorrhoid-relief product range and its presence across multiple national markets.

Anusol is documented as a medicine brand for hemorrhoid symptom relief, with a product family that includes creams, ointments, and suppositories. The brand's public identity is therefore built around local treatment of anorectal discomfort rather than around a broad consumer-health portfolio. Its products are designed for symptoms commonly associated with hemorrhoids, including itching, irritation, soreness, and discomfort. The available reference material does not identify a founding date or founder, and it does not provide enough evidence to reconstruct the original company behind the brand. Ownership, manufacturing arrangements, headquarters, and later corporate changes are likewise not established in the supplied sources. These omissions are important because a medicine brand's commercial owner and product registration holder may differ between countries and may change over time. Anusol's range has included several dosage forms. Creams and ointments provide topical application, while suppositories are intended for use in the anorectal area. Historical formulation information identifies zinc sulfate monohydrate in Anusol ointment and suppositories, where it functions as an astringent intended to reduce local irritation. Anusol Plus has been described as combining zinc sulfate monohydrate with pramoxine hydrochloride, an antipruritic ingredient used to help relieve itching. The reference material also states that current products may use zinc oxide instead of zinc sulfate monohydrate. Such statements should not be treated as a substitute for current national labeling, since formulations, strengths, indications, and product registrations may change. The brand has a cross-market naming history. In the United States and some other territories, comparable products have been marketed under the Tucks name, whereas the Anusol name continues to be used in Canada, the United Kingdom, and other markets. The shared or related brand presentation does not eliminate the need to check local labels, because a product sold under a different name may have different packaging, inactive ingredients, dosage instructions, or regulatory classification. In Canada, the brand is described as available without a prescription, as it is in the United States and the United Kingdom, although prescription status can vary in other jurisdictions. No dated milestones, documented campaigns, corporate acquisitions, leadership changes, recalls, scandals, or litigation are supported by the supplied reference material. The defensible history is therefore limited to the brand's continuing role as a market-specific hemorrhoid-relief medicine line and its evolution across dosage forms and national brand names.

A self-care and over-the-counter anorectal medicine brand focused on topical relief of hemorrhoid-related itching, irritation, soreness, and discomfort.

• Anusol creamsTopical hemorrhoid medicine

  Cream formulations in the Anusol range are intended for local application to help relieve symptoms associated with hemorrhoids and anorectal irritation. Depending on the market and specific registration, the formulation may contain astringent, soothing, or antipruritic ingredients. Directions, indications, and permitted age groups should be taken from the current local label.

• Anusol ointmentsTopical hemorrhoid medicine

  Anusol ointments are topical preparations associated with relief of hemorrhoid-related irritation, soreness, and discomfort. Historical product information identifies zinc sulfate monohydrate in some ointment formulations, while reference material indicates that current products may use zinc oxide instead. Exact ingredients and indications depend on the market and product version.

• Anusol suppositoriesAnorectal suppository

  Anusol suppositories provide a dosage form for local use in the anorectal area and are intended to relieve symptoms associated with hemorrhoids. Historical references associate the range with zinc sulfate monohydrate, although current formulations may differ. Consumers should verify the product's active ingredients, usage directions, contraindications, and availability on current national packaging.

• Anusol PlusCombination hemorrhoid medicine

  Anusol Plus is described as a combination product associated with zinc sulfate monohydrate and pramoxine hydrochloride. The latter is an antipruritic ingredient intended to help reduce itching, while the broader product range addresses hemorrhoid-related irritation and discomfort. Formula, strength, registration status, and availability should be checked in the relevant market.

1. Anusol